Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The SSX7 pseudogene (ENSG00000235350) is a genomic DNA sequence homologous to the functional SSX7 gene but is classified as a pseudogene, meaning it does not encode a functional protein[4][3]. Pseudogenes are typically nonfunctional DNA segments that can arise from gene duplication or retrotransposition and accumulate mutations that prevent them from encoding functional proteins[3]. Although some pseudogenes can be transcribed into RNA and influence regulatory networks, there is no evidence that the SSX7 pseudogene has a known biological function, clinical relevance, or role as a therapeutic target[2][4]. Its parent gene, SSX7, encodes a protein that may modulate transcription and is part of the synovial sarcoma X breakpoint family, but these features do not apply to its pseudogene counterpart[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SSX7 pseudogene (PsiSSX7).